Clinical Study | Office of Clinical Research

A Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.

Posted Date: Jan 27, 2020

Investigator: Caleb Adler
Specialties: ADD/ADHD, Psychiatry/Psychology
Type of Study: Drug

A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults with Attention-deficit/Hyperactivity Disorder (Trial 405-201-00014)

Criteria:

18 To 55 Years Of Age, Diagnosis Of Adhd

Keywords:

Adult, Add, Adhd

For More Information:

Emily Rummelhoff
513-558-4295
emily.rummelhoff@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List